Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers

Vaccine

Volumn 27, Issue 30, 2009, Pages 4074-4077

  Torrell, Josep Ma Ramon ^a   Aumatell, Cristina Masuet ^a   Ramos, Sergi Morchon ^a   Mestre, Laura Gavaldà ^a   Salas, Carme Micheo ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

ETEC; Inactivated cholera vaccine; Traveller's diarrhoea

Indexed keywords

CHOLERA VACCINE; DRINKING WATER;

ADULT; AFRICA; ARTICLE; ASIA; BETA CHAIN; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; FOOD SAFETY; HIGH RISK PATIENT; HUMAN; HYGIENE; IMMUNITY; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; SOUTH AND CENTRAL AMERICA; SPAIN; STRUCTURED INTERVIEW; TRAVEL; TRAVELLER DIARRHEA; VACCINATION;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; CHOLERA VACCINES; COHORT STUDIES; DIARRHEA; FEMALE; HUMANS; INCIDENCE; INFANT; INTERVIEWS AS TOPIC; MALE; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; SPAIN; TRAVEL; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; YOUNG ADULT;

EID: 67349206513     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.025     Document Type: Article

References (27)

1. von S.F., Tornieporth N., Waiyaki P., Lowe B., Peruski Jr. L.F., DuPont H.L., Mathewson J.J., and Steffen R. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 356 July (9224) (2000) 133-134
2. Hill D.R. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. Am J Trop Med Hyg 62 May (5) (2000) 585-589
3. Steffen R. Epidemiology of traveller's diarrhea. Clin Infect Dis 41 December (Suppl. 8) (2005) S536-S540
4. Black R.E. Epidemiology of travellers' diarrhea and relative importance of various pathogens. Rev Infect Dis 12 January (Suppl. 1) (1990) S73-S79
5. Jiang Z.D., Lowe B., Verenkar M.P., Ashley D., Steffen R., Tornieporth N., von S.F., Waiyaki P., and DuPont H.L. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 185 February (4) (2002) 497-502
6. Sack D.A., Sack R.B., Nair G.B., and Siddique A.K. Cholera Lancet 363 January (9404) (2004) 223-233
7. Zuckerman J.N., Rombo L., and Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis 7 August (8) (2007) 521-530
8. Centers for Disease Control Prevention. Prevention of specific infectious diseases-traveller's diarrhea. CDC Health Information for International Travel 2008 (2007) Available from wwwn. cdc. gov/travel/yellowBookCh4-Diarrhea. aspx. (Accessed July 6, chapter 4)
9. Gascon J. Epidemiology, etiology and pathophysiology of traveller's diarrhea. Digestion 73 Suppl. 1 (2006) 102-108
10. Salzman J. Committee to advise on tropical medicine and travel (CATMAT) and National Advisory Committee on Immunization (NACI). Statement on new oral cholera and travellers' diarrhea vaccination. Can Commun Dis Rep 31 (2005) 1-11
11. An Advisory Committee Statement (ACS). Statement on travellers' diarrhea. Can Commun Dis Rep 27 March (2001) 1-12
12. Clements J.D., and Finkelstein R.A. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli. Infect Immun 22 December (3) (1978) 709-713
13. Moseley S.L., and Falkow S. Nucleotide sequence homology between the heat-labile enterotoxin gene of Escherichia coli and Vibrio cholerae deoxyribonucleic acid. J Bacteriol 144 October (1) (1980) 444-446
14. Sixma T.K., Pronk S.E., Kalk K.H., Wartna E.S., van Zanten B.A., Witholt B., and Hol W.G. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351 May (6325) (1991) 371-377
15. Peltola H., Siitonen A., Kyronseppa H., Simula I., Mattila L., Oksanen P., Kataja M.J., and Cadoz M. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338 November (8778) (1991) 1285-1289
16. Scerpella E.G., Sanchez J.L., Mathewson III J.J., Torres-Cordero J.V., Sadoff J.C., Svennerholm A.M., DuPont H.L., Taylor D.N., and Ericsson C.D. Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travellers' diarrhea. J Travel Med 2 March (1) (1995) 22-27
17. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Neogy P.K., Stanton B., Huda N., Khan M.U., Kay B.A., and Khan M.R. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 158 August (2) (1988) 372-377
18. Millington K., Locke T., and Locke A. Occasional studies: adventure travel. Travel Tourism Analyst 4 (2001) 65-97
19. World Health Organization. Chapter 3: environmental health risks. International Travel and Health (2007), World Health Organization, Geneva
20. Cortes-Ortiz I.A., Rodriguez-Angeles G., Moreno-Escobar E.A., Tenorio-Lara J.M., Torres-Mazadiego B.P., and Montiel-Vazquez E. Outbreak caused by Escherichia coli in Chalco, Mexico. Salud Publica Mex 44 July (4) (2002) 297-302
21. Regua-Mangia A.H., Gomes T.A., Vieira M.A., Andrade J.R., Irino K., and Teixeira L.M. Frequency and characteristics of diarrhoeagenic Escherichia coli strains isolated from children with and without diarrhoea in Rio de Janeiro. Braz J Infect 48 February (2) (2004) 161-167
22. Redman C.A., Maclennan A., Wilson E., and Walker E. Diarrhea and respiratory symptoms among travelers to Asia, Africa, and South and Central America from Scotland. J Travel Med 13 July (4) (2006) 203-211
23. Freedman D.O., Weld L.H., Kozarsky P.E., Fisk T., Robins R., von Sonnenburg F., et al. Spectrum of Disease and relation to place of exposure among ill returned travelers. N Engl J Med 354 (2006) 119-130
24. Lopez-Gigosos R., Garcia-Fortea P., Reina-Dona E., and Plaza-Martin E. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS. Travel Med Infect Dis 5 November (6) (2007) 380-384
25. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Khan M.R., Stanton B.F., Kay B.A., Khan M.U., Yunus M., and Atkinson W. Field trial of oral cholera vaccines in Bangladesh. Lancet 2 July (8499) (1986) 124-127
26. Sanchez J.L., Vasquez B., Begue R.E., Meza R., Castellares G., Cabezas C., Watts D.M., Svennerholm A.M., Sadoff J.C., and Taylor D.N. Protective efficacy of oral wholecell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet 344 November (8932) (1994) 1273-1276
27. Lucas M.E., Deen J.L., von S.L., Wang X.Y., Ampuero J., Puri M., Ali M., Ansaruzzaman M., Amos J., Macuamule A., Cavailler P., Guerin P.J., Mahoudeau C., Kahozi-Sangwa P., Chaignat C.L., Barreto A., Songane F.F., and Clemens J.D. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352 February (8) (2005) 757-767